LICENSE AND ASSET PURCHASE AGREEMENT DATED AS OF MARCH 30, 2009 BETWEEN GENZYME CORPORATION, AND BAYER SCHERING PHARMA AGLicense and Asset Purchase Agreement • August 9th, 2010 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 9th, 2010 Company Industry JurisdictionThis License Agreement (the “Agreement”), dated as of May 29, 2009 (the “Effective Date”), is between Genzyme Corporation (“Genzyme”) and Alcafleu Management GmbH & Co. KG (“Alcafleu”).
FIRST AMENDMENT TO LEASEGenzyme Corp • August 9th, 2010 • Biological products, (no disgnostic substances) • Massachusetts
Company FiledAugust 9th, 2010 Industry JurisdictionTHIS FIRST AMENDMENT TO LEASE (hereinafter referred to as the “Amendment”) is dated as of this 21st day of May, 2010 by and between FC 64 SIDNEY, INC., a Massachusetts corporation (“Landlord”) and GENZYME CORPORATION, a Massachusetts corporation (“Tenant”). Capitalized terms used herein and not otherwise defined shall have the meaning ascribed to such term in the Lease.
LICENSE AGREEMENTLicense Agreement • August 9th, 2010 • Genzyme Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 9th, 2010 Company Industry JurisdictionGENZYME CORPORATION, a corporation organized and existing under the laws of the Commonwealth of Massachusetts and having its principal office at One Kendall Square, Cambridge, Massachusetts 02139 (hereinafter referred to as “GENZYME”) and
MASTER SUPPLY AGREEMENTMaster Supply Agreement • August 9th, 2010 • Genzyme Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 9th, 2010 Company Industry JurisdictionTHIS MASTER SUPPLY AGREEMENT (hereinafter referred to as the “Master Agreement”) with an effective date of this 30th day of June 2010 (the “Effective Date”) is made by and among Genzyme Corporation, a Massachusetts corporation having its headquarters at 500 Kendall Street, Cambridge, Massachusetts 02142, U.S.A., Genzyme Ireland Limited, a wholly-owned subsidiary company of Genzyme Corporation, organized under the laws of the Republic of Ireland with a principal place of business in Waterford, Ireland, and its and their Affiliates (collectively, hereinafter referred to as “Genzyme”), and Hospira Worldwide, Inc., a Delaware corporation having its headquarters at 275 North Field Drive, Lake Forest, Illinois 60045, U.S.A. (hereinafter referred to as “Hospira”).